-
Ixekizumab Efficacious and Cost Effective for Biologic Treatment of PsO
08 Jul 2025 15:11 GMT
… methotrexate, phototherapy, and biologics including adalimumab, ustekinumab, guselkumab, secukinumab, and … outcomes to comprehensively evaluate treatment impacts including both clinical … and cost‐effectiveness of treatments for psoriasis integrating clinician‐ …
-
Beyond the Label: Evaluating Bimekizumab’s Mental Health Profile in Psoriasis Treatment
07 Jul 2025 21:21 GMT
… adalimumab, and etanercept.6
Favorable safety data: In pooled clinical trials … initiating treatment, clinicians should conduct pre-treatment screening … with supportive clinical trial and real-world … physician assistant and medical writer in Connecticut. …
-
Top 10 Best-Selling Drugs
07 Jul 2025 19:11 GMT
… MFN.
“Importing socialized medicine will not make Americans … and CEO of the Biotechnology Innovation Organization (BIO).
… highlighted by GEN.
Treatments ranked number 11 through … ) from Regeneron Pharmaceuticals and Bayer
Humira® (adalimumab) from AbbVie, …
-
Regarding “Effectiveness and Persistence of Anti-TNFα Treatment in Patients with Rheumatoid Arthritis - A 7 Years Real-World Cohort Study” [Letter]
07 Jul 2025 11:53 GMT
… of three anti-TNFα therapies (adalimumab, etanercept, and infliximab) in … real-world treatment behavior beyond the controlled conditions of clinical trials.
Nevertheless … aligns with the evolving 6P Medicine framework (Personalized, Predictive, Preventive, …
-
Celltrion Launches Stoboclo-Osenvelt in U.S. Osteoporosis Market
08 Jul 2025 05:54 GMT
… .S. Food and Drug Administration (FDA) for full-label … Remsima SC), ‘Yuflyma’ (adalimumab), and ‘Steqeyma’ (ustekinumab), Celltrion … (PBMs), making pharmaceutical companies' sales … bone disease treatment options, thereby improving medical accessibility. We …
-
Review Highlights Most Effective HS Therapies Based on HiSCR-50 Responses
07 Jul 2025 17:17 GMT
… treatments by HiSCR-50 response in the following dosages: adalimumab … Zucker School of Medicine at Hofstra… trial registries—ClinicalTrials.gov and the Cochrane Central Register of Controlled Trials … ) incidence, and drug discontinuation resulting from AEs …
-
Celltrion launches Prolia, Xgeva biosimilars in US, turning up heat on Amgen and Sandoz
08 Jul 2025 01:53 GMT
… hit pharmacy shelves.
The drugs are biosimilar versions of … .
The Korean drugmaker received full-label FDA approval in March … used for its infliximab, adalimumab and ustekinumab biosimilars.
At … to gain access to Medicare and commercial formularies.
Samsung …
-
Novel Scoring System Accurately Tracks Crohn’s Ulcers
05 Jul 2025 20:12 GMT
… videos from a phase 3b adalimumab trial (NCT00348283; n = 112 … trial (NCT02031276; n = 99). Multiple central readers, masked to treatment … reassessed 44 post-treatment videos to evaluate … validated, reliable, and treatment-responsive continuous index for …
-
The Top 5 Biosimilar Articles for the Week of June 30
04 Jul 2025 15:15 GMT
… significantly, reflecting evolving treatment patterns in inflammatory bowel … and cost savings using adalimumab biosimilars over time.
… dupilumab, enhancing access to treatment in Europe and Latin … raises critical concerns about FDA standards, physician trust, …
-
IL-6 Signaling in Immunopathology: From Basic Biology to Selective Therapeutic Intervention
05 Jul 2025 09:42 GMT
… , placebo-controlled phase 3 trial of satralizumab in patients with … phase I trials, no severe or serious treatment-emergent adverse … complex cytokine. Nat Rev Drug Discov. 2018;17(6): … . Olokizumab versus placebo or adalimumab in rheumatoid arthritis. N …